![Page 1: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/1.jpg)
Regional Training on Strategic and Operational Planning in HIV & AIDS S P
Cost-Effectiveness Analysis (CEA)
Julian Naidoo Barry Kistnasamy
![Page 2: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/2.jpg)
S PThe Cost-Effectiveness Analysis
• A form of economic evaluation that allows for the comparison of the costs (in monetary units) and consequences (in natural units) of two or more alternatives.
• It is used when competing alternatives produce a common health consequence – When there is no evidence that the alternatives have a
different effect on health, this analysis is used solely to findthe alternative which has the greatest outcome per input
• It is useful when you have limited resources and are trying to make the most strategic choice.
![Page 3: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/3.jpg)
S PCEA answers the following questions:
• Given that it has been decided that a goal is to be achieved, what is the best way of doing do?
• What is the best way of spending a given budget?
• Only for comparing two options with the same goal.
• It measures technical efficiency only – not allocative efficiency
![Page 4: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/4.jpg)
S PObjectives of this session
• To understand the concepts of cost effectiveness analysis and sensitivity analysis
• To understand the steps involved in CEA and SA
• To be able to interpret cost effectiveness measures
• To equip participants with the Economic Evaluation check list
![Page 5: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/5.jpg)
S PCost-Effective Analysis
•It requires the identification of a standard to which the alternative health consequences can be compared. And requires DATA.
Examples of Measures of Effectiveness
Program Possible measures of effectiveness
Treatment of Hypertension Blood Pressure reduction in MmHg
PMTCT programme % reduction in rate of Mother to Child Transmission
Treatment of Hypercholesterolemia % reduction in blood cholesterol
Asthma Days without attack
ARV treatment programme Life years gained
![Page 6: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/6.jpg)
S PSteps to Complete a CEA
1. STRUCTURING OF THE PROBLEMDefine:
i. 1. Objectiveii. 2. Perspectiveiii. 3. Time Frameiv. 4. Analytical Horizon
![Page 7: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/7.jpg)
S P
2. IDENTIFICATION OF RELEVANT ALTERNATIVESThe alternatives should be:
i. 1. Appropriate for the objective public
ii. 2. ComparablePossible Alternatives:
* 1. Actual Practice* 2. New Practice* 3. Doing nothing
Steps to Complete a CEA…
![Page 8: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/8.jpg)
S P
3. IDENTIFICATION OF METHODS FOR MEASURING RESULTS
i. i. Result categories:
Intervals• Number of people using condoms as a
result of an education intervention
Final• Number of HIV/AIDS infections avoided as
a result of the intervention
Steps to Complete a CEA…
![Page 9: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/9.jpg)
S P
3. IDENTIFICATION OF METHODS FOR MEASURING RESULTS Cont.
ii. ii. Adverse Effects of the Intervention
iii. iii. Identification of Costs
- Costs of the program/intervention
- Costs avoided or avoidable through - the program/intervention
- Costs of lost productivity
Steps for Completing a CEA…
![Page 10: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/10.jpg)
S PSources for CEA Data
• Cost data sources:– Retrospective data: financial records, activity data– Prospective data: obtain quantities (by types) of
inputs required through interactive interviews with experts
• Effectiveness data sources: clinical trials, randomised controlled trials, whatever appropriate to the programme– Final health output (life years gained, number of
heart attacks prevented, etc)
![Page 11: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/11.jpg)
S PDesign
• Data Collection
in out
![Page 12: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/12.jpg)
S PDesign
• Conceptual Model– Intervention flow diagram– Decision tree or another form to outline
the process (Markov Model) – The quality of the results depends on
the quality of the model
![Page 13: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/13.jpg)
S PCost Effectiveness Ratio
• Alternatives may differ in terms of costs and effects• A ratio is produced for each alternative
– The numerator is cost– The denominator is the health effects (e.g life years saved)
• The cost-effectiveness ratio is a measure of “cost per unit of health effect”
• Distinction between average C/E ratio and incremental C/E ratio is essential!
![Page 14: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/14.jpg)
S PAverage and Incremental C/E ratios
• An average C/E ratio is equal to the total cost of a programme divided by the effectiveness of the prorgamme compared to “doing nothing” (i.e the base-case alternative)
• An incremental C/E ratio is the incremental cost of a programme divided by the incremental effectiveness compared to the next most effective programme
• If only one programme is compared with “doing nothing” then the incremental C/E ration = average C/E ratio
![Page 15: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/15.jpg)
S PAverage C/E ratio use
• Two programmes, A and B, are defined as independent if the costs and effectiveness of programme a (B) are not affected by whether programme B (A) is implemented or not.
• E.g the treatment of ulcer patients and the treatment of arthritis patients
• Use AVERAGE cost-effectiveness
![Page 16: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/16.jpg)
S PIncremental C/E ratio use
• For mutually exclusive programmes:• If implementing programme A (B) means that
programme B (A) cannot also be implemented• If programmes A and B can both be implemented
physically, but implementing a (B) means that the costs and/or effectiveness of B (A) change
• 3 alternatives: only A, only B, or both A and B• Use INCREMENTAL cost-effectiveness
![Page 17: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/17.jpg)
S PCharacteristics of the CEA
1. Measurement of the Effectiveness of the Intervention:
– Efficiency of the intervention (treatment, vaccines)
– Sensitivity and specificity of laboratory exams– Disease prevalence– Risk factor prevalence– Participation, coverage of a community activity
![Page 18: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/18.jpg)
S P
2. Risk of indirect effects of the intervention3. Risk of disease or injury with and without the
intervention– Risk of primary disease or injury avoided– Risk of complications or secondary injury or disease
avoided
Characteristics of CEA
![Page 19: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/19.jpg)
S P
4. Net Costs of an Intervention– Medical and non-medical costs
• Of the intervention • Of the disease
– Loss of productivity • Of the intervention• Of the disease
Characteristics of CEA
![Page 20: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/20.jpg)
S PLimitations of Incremental CEA
• Not generalisable across settings because the starting points might be different
• Does not say if current practice is effective –only if the suggested incremental change is effective
![Page 21: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/21.jpg)
S PLimitations of CEA
• Where the programmes yield more than one kind of beneficial effect, CEA might not resolve the problem of option selection because it can only compare along one output type at a time.
• Cannot compare interventions which have differing impacts on both mortality and morbidity
![Page 22: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/22.jpg)
S PLimitations of CEA cont.
• Difficult to make policy decision based only on the comparison of the C/E ratios
• When using intermediate outcomes, it is often difficult to link these definitively with the final outcome eg reduction in HIV prevalence, reduction in AIDS-related deaths
• CEA cannot compare programmes with different goals!!
![Page 23: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/23.jpg)
S PCEA
• Summary
![Page 24: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/24.jpg)
S PDesired Outcomes
Essentially we want two main outcomes from our HIV/AIDS Prevention and Treatment & Care programmes:– A reduction in the number of infections; and– An increase in the number of healthy years of life for
those who are infected and receiving treatment and care.
![Page 25: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/25.jpg)
S PPrevention Indicator
• Therefore, in evaluating the cost effectiveness of Prevention strategies we compare the cost of competing strategies per infections averted.
![Page 26: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/26.jpg)
S PTreatment & Care Indicator
• Similarly, in evaluating the cost effectiveness of Treatment & Care strategies we compare the cost of competing strategies per years of life gained.
![Page 27: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/27.jpg)
S PConclusion
• The information provided by cost-effectiveness analysis allows for: – identification of those interventions that have the
potential to reduce the impact of the epidemic– more effective priority setting by providing choice from
a viable range of options.
![Page 28: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/28.jpg)
S PDiscussion
• Should CEA include changes in productivity from the social perspective?
• Should it consider the consequences of future medical costs for people whose deaths were avoided?
![Page 29: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/29.jpg)
Regional Training on Strategic and Operational Planning in HIV & AIDS S P
Cost Effectiveness-Analysis (CEA) II –Sensitivity Analysis
![Page 30: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/30.jpg)
S PInterpreting Measures of Cost-Effectiveness
• Strong Dominance– One program shows dominance over another if is
more effective and less costly
• Extended Dominance (Weak Dominance)– There is extended dominance when a combination of
two programs shows greater cost-effectiveness than another
– Extended dominance rules out any intervention that has an incremental cost-effectiveness ratio that is greater than that of a more effective intervention
![Page 31: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/31.jpg)
S P
0
100000
200000
300000
400000
500000
600000
0 5000 10000 15000 20000 25000
FIGURE 5.5 Drummond
Cos
t
Health Outcome
![Page 32: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/32.jpg)
S P
0
100000
200000
300000
400000
500000
600000
0 5000 10000 15000 20000 25000
FIGURE 5.5 Drummond
A
B
C
![Page 33: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/33.jpg)
S PEconomic Evaluation Checklist
1. Was a well-defined question posed in answerable form?
2. Was a comprehensive description of the competing alternatives given?
3. Was there evidence that the programs effectiveness (efficacy) had been established?
4. Were all important and relevant costs and consequences for each alternative identified?
![Page 34: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/34.jpg)
S PEconomic Evaluation Checklist
5. Were costs and consequences measured accurately in appropriate physical units?
6. Were costs and consequences valued credibly?
7. Were costs and consequences adjusted for different timing?
![Page 35: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/35.jpg)
S PEconomic Evaluation Checklist
8. Was an incremental analysis of cost and consequences of alternatives performed?
9. Was allowance made for uncertainty in the estimates of costs and consequences? (SA done?)
10.Did the presentation and discussion of study results include all issues of concern to users?
![Page 36: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/36.jpg)
S PSoftware used for CEA
• SMLTREE• Data 3.0• DECISION MAKER• DECAID• TREE AGE• Excel
![Page 37: Cost-Effectiveness Analysis (CEA) - World Banksiteresources.worldbank.org/INTHIVAIDS/Resources/375798... · Regional Training on Strategic and Operational Planning in HIV & AIDS S](https://reader031.vdocuments.us/reader031/viewer/2022030411/5a9de1de7f8b9ae0108cf7aa/html5/thumbnails/37.jpg)
S PThanks
With thanks to Teresa Guthrie (CEGAA), Susan Cleary (Health Economics Unit, UCT) and Atanacio Mendoza (INSP, Mexico)